Company intelligence / Profile preview

Epipole

Rosyth, Scotland, United Kingdomepipole.com ↗

Ownership: Private
Development stage: Commercial

Overview

Epipole has commercialized the epiCam family of handheld digital fundus cameras for rapid and non-invasive retinal imaging. The devices are used globally in clinical practice to aid in the diagnosis and management of ophthalmic diseases. No drug or therapeutic clinical results; product adoption noted in multiple markets including Asia and the US.

Therapeutic areas: Ophthalmology
Modalities: Device (retinal imaging)
Industry: Medical Imaging

Partnerships

SynCore Biotechnology Co., Ltd. – distribution partner for Taiwan market

Beyond the preview

Go deeper on Epipole.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epipole.

Explore the full profile